Tandem Diabetes Care Inc (TNDM) - Total Assets
Based on the latest financial reports, Tandem Diabetes Care Inc (TNDM) holds total assets worth $1.15 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore TNDM cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Tandem Diabetes Care Inc - Total Assets Trend (2011–2025)
This chart illustrates how Tandem Diabetes Care Inc's total assets have evolved over time, based on quarterly financial data. See what is Tandem Diabetes Care Inc's book value for net asset value and shareholders' equity analysis.
Tandem Diabetes Care Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Tandem Diabetes Care Inc's total assets of $1.15 Billion consist of 70.2% current assets and 29.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.3% |
| Accounts Receivable | $165.49 Million | 18.8% |
| Inventory | $128.77 Million | 14.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.72 Million | 1.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Tandem Diabetes Care Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see TNDM market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tandem Diabetes Care Inc's current assets represent 70.2% of total assets in 2025, an increase from 70.0% in 2011.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, down from 61.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 18.8% of total assets.
Tandem Diabetes Care Inc Competitors by Total Assets
Key competitors of Tandem Diabetes Care Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Tandem Diabetes Care Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.58 | 2.30 | 6.42 |
| Quick Ratio | 3.07 | 1.81 | 5.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $639.14 Million | $375.26 Million | $589.56 Million |
Tandem Diabetes Care Inc - Advanced Valuation Insights
This section examines the relationship between Tandem Diabetes Care Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.99 |
| Latest Market Cap to Assets Ratio | 1.18 |
| Asset Growth Rate (YoY) | -8.9% |
| Total Assets | $881.11 Million |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Tandem Diabetes Care Inc's assets above their book value (1.18x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Tandem Diabetes Care Inc's assets decreased by 8.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Tandem Diabetes Care Inc (2011–2025)
The table below shows the annual total assets of Tandem Diabetes Care Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $881.11 Million | -8.94% |
| 2024-12-31 | $967.66 Million | +1.57% |
| 2023-12-31 | $952.66 Million | -9.51% |
| 2022-12-31 | $1.05 Billion | +16.31% |
| 2021-12-31 | $905.14 Million | +26.34% |
| 2020-12-31 | $716.41 Million | +119.69% |
| 2019-12-31 | $326.11 Million | +58.08% |
| 2018-12-31 | $206.29 Million | +116.36% |
| 2017-12-31 | $95.35 Million | -15.17% |
| 2016-12-31 | $112.39 Million | -10.17% |
| 2015-12-31 | $125.12 Million | +17.52% |
| 2014-12-31 | $106.46 Million | -34.37% |
| 2013-12-31 | $162.22 Million | +307.40% |
| 2012-12-31 | $39.82 Million | +184.86% |
| 2011-12-31 | $13.98 Million | -- |
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and … Read more